Extract
Sarcoidosis is a systemic disease of an unknown aetiology, in which noncaseating granulomas are formed in one or multiple organs, with pulmonary involvement in >90% of the sarcoidosis patients [1]. Pulmonary hypertension (PH), defined as a mean pulmonary artery pressure of ≥25 mmHg by right heart catheterisation (RHC) [2], is a well recognised complication of sarcoidosis, associated with significant increase in mortality [3, 4]. Although the first case of PH in sarcoidosis was described in 1949 [5], the exact prevalence remains unclear.
Abstract
The prevalence of pulmonary hypertension in sarcoidosis seems to differ between ethnicities and was never investigated in a Caucasian cohort. This study shows a prevalence of 3% in a Caucasian cohort, significantly lower compared to other ethnicities. http://bit.ly/2kRMrap
Footnotes
Conflict of interest: M.P. Huitema has nothing to disclose.
Conflict of interest: A.L.M. Bakker has nothing to disclose.
Conflict of interest: J.J. Mager has nothing to disclose.
Conflict of interest: B.J.W.M. Rensing has nothing to disclose.
Conflict of interest: F. Smits has nothing to disclose.
Conflict of interest: R.J. Snijder has nothing to disclose.
Conflict of interest: J.C. Grutters has nothing to disclose.
Conflict of interest: M.C. Post has nothing to disclose.
Support statement: Funding was received from ZonMw (The Netherlands Organisation for Health Research and Development). Funding information for this article has been deposited with the Crossref Funder Registry.
- Received November 29, 2018.
- Accepted June 12, 2019.
- Copyright ©ERS 2019
LIBRARY USERS
Log in through your institution
Purchase access
